Treatment of BV With First Deqularum and Then Direkt After Clindamycin
NCT ID: NCT04067531
Last Updated: 2020-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
50 participants
INTERVENTIONAL
2020-08-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cure rate will be followed up after 1 month and then after 6 month
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment of BV
all patients be treated with first Deqularum then with clindamycin Cream,
treatment of BV with first Deqularum and then direkt after with vaginal clindamycin
All patients will get the same treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
treatment of BV with first Deqularum and then direkt after with vaginal clindamycin
All patients will get the same treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Skaraborg Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Per-Goran Larsson
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
P-G Larsson
Role: PRINCIPAL_INVESTIGATOR
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ob/Gyn, Skaraborgshospital Skövde
Skövde, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12
Identifier Type: -
Identifier Source: org_study_id